CRADB On Other Exchanges
Symbol
Exchange
Stockholm
London

c-rad ab-b shs (CRADB) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for C-RAD AB-B SHS (CRADB)
\

Related News

No related news articles were found.

c-rad ab-b shs (CRADB) Related Businessweek News

No Related Businessweek News Found

c-rad ab-b shs (CRADB) Details

C-RAD AB, together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst HD, a surface image guided radiation therapy (SIGRT) solution; Catalyst, a 4D SIGRT solution; Catalyst PT, an advanced solution for particle therapy; Catalyst Tomo, an enhanced positioning solution for tomotherapy; Cyrpa laser positioning products; and Gemini, an X-ray detector optimized for electronic portal imaging device in radiation therapy. The company offers installation, application training, and aftersales services. The company has partnership agreement with XECAN to develop products to advance patient positioning and resource management within radiation therapy. C-RAD AB was founded in 2004 and is headquartered in Uppsala, Sweden.

54 Employees
Last Reported Date: 05/8/19
Founded in 2004

c-rad ab-b shs (CRADB) Top Compensated Officers

CEO & President
Total Annual Compensation: kr1.9M
Compensation as of Fiscal Year 2017.
c-rad ab-b shs
C-Rad AB Announces Consolidated and Parent Earnings Results for the First Quarter Ended March 2019

C-Rad AB announced consolidated and parent earnings results for the first quarter ended March 2019. For the quarter, on consolidated basis, the company reported revenues of SEK 47.3 million, operating income of SEK 1.2 million and net income of SEK 0.8 million or SEK 0.02 per basic and diluted share against revenues of SEK 33.8 million, operating loss of SEK 4.7 million and net loss of SEK 4.9 million or SEK 0.16 per basic and diluted share a year ago. For the quarter, the parent company reported revenue of SEK 3.6 million against SEK 4.0 million a year ago. Operating loss was SEK 0.1 million against income of SEK 1.0 million a year ago. Net loss was SEK 0.1 million against net income of SEK 0.9 million a year ago.

Community Health Network Decides for C-RAD's Innovative SIGRT Solution

C-RAD and Community Health Network announced an agreement to equip three of their cancer centers located in the state of Indiana with C-RAD's surface tracking solution based on Catalyst and Sentinel 4DCT. Community Cancer Centers are collaborating with the MD Anderson Cancer Network(R), a program of MD Anderson Cancer Center. Community Health Network is Central Indiana's leader in providing convenient access to exceptional healthcare services. The Catalyst(TM) system will be delivered with the complete software suite with modules for Respiratory Gating, Patient Setup and Positioning and Motion Monitoring. The C-RAD SIGRT solution provides a continuous monitoring of the patient during a treatment fraction. Patient motion above a clinically defined threshold will interrupt the treatment beam. C-RAD Sentinel 4DCT is an easy-to-use, laser-based optical surface scanning system with functionality for 4D CT reconstruction and gated imaging in a CT room. It also provides reference images for patient positioning.

C-RAD Appoints Therese Bjorklund as Interim CFO

C-RAD announces that Therese Bjorklund has been appointed Interim Chief Financial Officer with immediate effect, succeeding Cecilia Danckwardt-Lilliestrom. Therese has been the CFO for C-RAD until October 15, 2018. The recruitment process for a new CFO will be started immediately.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CRADB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CRADB.
View Industry Companies
 

Industry Analysis

CRADB

Industry Average

Valuation CRADB Industry Range
Price/Earnings 44.2x
Price/Sales 5.8x
Price/Book 12.5x
Price/Cash Flow 33.2x
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact C-RAD AB-B SHS, please visit www.c-rad.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.